| 1/8 | US=85 / Biol/Mol Shin DY, Ryu CH, Lee WS, Kim DC, Kim SH, Hah YS, Lee SJ, Shin SH, Kang HS, Choi YH. Induction of apoptosis and inhibition of invasion in human hepatoma cells by anthocyanins from Meoru. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 137-48. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. ANTOCIANINAS; APOPTOSE; INVASAO; CELULA HEP3B; BCL-2; CASPASES; CANCER |
| 2/8 | US=85 / Biol/Mol Lee M, Sorn S, Baek S, Jang S, Kim S. Antioxidant and apoptotic effects of korean ehite ginseng extracted with the same ratio of protopanaxadiol and protopanaxatriol saponins in human hepatoma HepG2 cells. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 217-27. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. PD:PT; CELULAS HEPG2; GINSENOSIDE; PEROXIDO LIPIDICO; MAPK; GLUTATIONA PEROXIDASE; CATALASE; CITOCROMO C; CASPASE-3 |
| 3/8 | US=23-D / Câncer Nakamura H, Yoshida K, Tomita Y. Hepatocellular carcinoma: prognosis using hepatoma-derived growth factor immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: liver cancer. New York: Springer, 2009. p. 333-42. ISBN 978-1-4020-9803-1. CARCINOMA HEPATOCELULAR; HEPATOMA. FATOR DE CRESCIMENTO DERIVADO; METODOS DE IMUNO-HISTOQUIMICA; ANALITICA; HEPATOMA DERIVADO. EVOLUCAO |
| 4/8 | US=23-B / Câncer Tomita Y, Uyama H, Nakamura H. Pancreatic cancer: hepatoma-derived growth factor as a prognostic factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 183-9. ISBN 978-1-4020-8899-5. CANCER; CANCER GASTROINTESTINAL; CANCER DE PANCREAS; HEPATOMA; FATOR DE CRESCIMENTO DERIVADO; FATOR PROGNOSTICO; IMUNOHISTOQUIMICA |
| 5/8 | US=84 / Biol/Mol Kim TA, Kim SJ. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: mechanisms of TGF-B-induced apoptosis in cancer cells. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 199-211. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 6/8 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 7/8 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 8/8 | US=36-A / Gastro La Quaglia MP. Hepatic tumors in childhood. In: Blumgart LH. Surgery of the biliary tract, and pancreas. 4th ed. Philadelphia: Elsevier Saunders, 2007. p. 1159-77. (v.2) ISBN 978-1-4160-3256-8. TUMORES HEPATICOS NA INFANCIA; HEPATOBLASTOMA; CARCINOMA HEPATOCELULAR; HEPATOMA; SARCOMA EMBRIONARIO; RHABDOID TUMOR HEPATICO PRIMARIO; ANGIOSARCOMA; LEIOMIOSSARCOMA; CRIANCA COM UMA MASSA HEPATICA; TUMORES HEPATICOS BENIGNOS |